Heron Therapeutics Appoints Thomas Cusack to Board of Directors

Heron Therapeutics, Inc. announced the appointment of Thomas Cusack to its Board of Directors on October 27, 2025. Mr. Cusack brings extensive experience in corporate finance, investment management, and corporate governance, having served as a Managing Director at Starboard Value LP and previously as an investment banker at Barclays Capital and Lehman Brothers. His appointment is part of a Cooperation Agreement between Heron Therapeutics and Rubric Capital Management LP. Mr. Cusack will serve on the Nominating and Corporate Governance Committee and will receive standard non-employee director compensation. The company also issued a press release on October 29, 2025, detailing this appointment.